|
CID16020046
- 英文名称：CID16020046
- 品牌：WYTSCI
- 产地：进口
- 型号：1MG
- 货号：WT-AY-B11543
- cas：834903-43-4
- 价格： ￥1/mg
- 发布日期： 2025-04-10
- 更新日期： 2025-04-30
产品详请
| 产地 | 进口 |
| 品牌 | WYTSCI |
| 货号 | WT-AY-B11543 |
| 用途 | 科研检测 |
| 英文名称 | CID16020046 |
| 包装规格 | 1MG |
| CAS编号 | 834903-43-4 |
| 别名 | CID16020046 |
| 纯度 | 98+% |
| 分子式 | |
| 是否进口 | 是 |
纯度:>98% by HPLC;NMR (Conforms)
分子式:C25H19N3O4
分子量:425.44
溶剂:DMSO (45 mg/ml)
性状:White to off-white solid
存储:-20°C
Activity (short version):GPR55 antagonist
Function / Pharmacology:CID16020046 is a selective GPR55 antagonist.1 In HEK293 cells expressing GPR55, the compound behaves as an antagonist on lysophosphatidylinositol (LPI)-mediated Ca2+ release but was inactive on cells expressing CB1 and CB2. It blocks LPI-induced migration of colon cancer cells.2 It displays protective effects against oxidized LDL-induced inflammation3, mitigates advanced glycation end products-induced chondrocyte activation4, and displays anti-inflammatory effects in various cells5,6. A useful tool for studying the role of GPR55 in cellular physiology.
分子式:C25H19N3O4
分子量:425.44
溶剂:DMSO (45 mg/ml)
性状:White to off-white solid
存储:-20°C
Activity (short version):GPR55 antagonist
Function / Pharmacology:CID16020046 is a selective GPR55 antagonist.1 In HEK293 cells expressing GPR55, the compound behaves as an antagonist on lysophosphatidylinositol (LPI)-mediated Ca2+ release but was inactive on cells expressing CB1 and CB2. It blocks LPI-induced migration of colon cancer cells.2 It displays protective effects against oxidized LDL-induced inflammation3, mitigates advanced glycation end products-induced chondrocyte activation4, and displays anti-inflammatory effects in various cells5,6. A useful tool for studying the role of GPR55 in cellular physiology.
